Category

Genome Editing Market Size, Share, Opportunities, COVID 19 Impact, And Trends By Technology (CRISPR, TALEN, ZFN), By Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), And By Geography – Forecast From 2019 To 2024

Published: Apr 2021 | Report Code:  KSI061612981 | Pages:  100

The genome editing market is projected to grow at a CAGR of 12.39% during the forecast period, reaching a total market size of US$6.385 billion in 2024 from US$3.168 billion in 2018. Genome editing or gene editing is a group of technologies that give scientists the ability to change an organism's DNA by adding, removing, or altering genetics. Rising government funding and increasing genomics projects are boosting the growth of the market. The growing prevalence of cancer and other diseases and technological advancements in genome editing is also uplifting market growth. An increase in R&D expenditure and growth of biotechnology and pharmaceutical industries will also propel market growth. However, the negative perception of people about genome editing coupled with UNESCO scientists advocating for the ban of genome editing can hamper the market growth. Geographically, the North American region has a significant market share on account of the increasing use of genetically modified crops and the increasing focus on the development of gene therapies in the region. Early introduction of technology coupled with highly skilled labor and workforce, developed health infrastructure and presence of key market players are driving the market in the region.

The “Genome editing market – Forecasts from 2019 to 2024” is an exhaustive study that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key markets, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by technology, application, and geography.

The genome editing market has been segmented based on technology, application and geography. Based on technology the market has been segmented into CRISPR, TALEN, and ZFN. Based on application the market has been segmented into cell line engineering, animal genetic engineering, and plant genetic engineering.

Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024. The global market has been broken down into North America, South America, Europe, the Middle East and Africa, and the Asia Pacific regions. The report also analyzes 15 countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.

Major players in the genome editing market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the genome editing market.

Genome Editing Market Scope:

Report Metric Details
 Market size value in 2018  US$3.168 billion
 Market size value in 2024  US$6.385 billion
 Growth Rate  CAGR of 12.39% from 2018 to 2024
 Base year  2018
 Forecast period  2019–2024
 Forecast Unit (Value)  USD Billion
 Segments covered  Technology, Application, And Geography
 Regions covered  North America, South America, Europe, Middle East and Africa, Asia Pacific
 Companies covered  Thermo Fisher Scientific Inc., Merck KGaA, Horizon Discovery Group plc, GenScript,   Sangamo Therapeutics, Integrated DNA Technologies, Inc., Lonza Group Ltd., BEX   CO., LTD., OriGene Technologies, Inc., Transposagen Biopharmaceuticals, Inc.
 Customization scope  Free report customization with purchase

Segmentation:

  • By Technology
    • CRISPR
    • TALEN
    • ZFN
  • By Application
    • Cell Line Engineering
    • Animal Genetic Engineering
    • Plant Genetic Engineering
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • Germany
      • France
      • United Kingdom
      • Others
    • Middle East and Africa
      • Israel
      • South Africa
      • Others
    • Asia Pacific
      • China
      • Japan
      • South Korea
      • India
      • Others

Frequently Asked Questions (FAQs)

Q1. What will be the genome editing market size by 2024?
A1. The genome editing market is projected to reach a total market size of US$6.385 billion by 2024.
 
Q2. What is the size of the global genome editing market?
A2. Genome Editing market was valued at US$3.168 billion in 2018.
 
Q3. What are the growth prospects for genome editing market?
A3. The global genome editing market is projected to grow at a CAGR of 12.39% during the forecast period.
 
Q4. What factors are anticipated to drive the genome editing market growth?
A4. Rising government funding and increasing genomics projects are boosting the growth of the genome editing market. 
 
Q5. Which region holds the largest market share in the genome editing market?
A5. Geographically, the North American region has a significant share in the genome editing market on account of the increasing use of genetically modified crops and the increasing focus on the development of gene therapies in the region.

Explore custom options available with this study:

  • Request customization

  • Buy sections of the study

  • Buy country specific report

  • Request excel, Historical data

  • Subscription inquiry

  • Request special pricing

Our Value Proposition

Analyst Support

All our studies come with 2 months of analyst support.

Confidentiality

We are in compliance with the global privacy laws.

OUR CLIENTS